Skip to main content
. 2021 Feb 5;10:596677. doi: 10.3389/fonc.2020.596677

Figure 4.

Figure 4

Kaplan-Meier estimates of 2-year outcomes in the HSCT and chemotherapy arms in MRD re-emergent group. (A) OS, (B) CIR.